Abstract
Since late 1950s the main strategies to treat cancer, besides surgery, have been radiotherapy or chemotherapy. These approaches work primarily by damaging proliferating cells at the level of DNA replication or cell division, and inducing apoptotic cell suicide as a secondary response to the damage. In recent years, efforts to improve cancer therapy have focused on the development of more selective, biological mechanism based approaches that can help to overcome tumor resistance as well as minimize toxic side effects. In the present review new strategies and new targets for biological cancer therapy will be discussed. In particular, new angiogenic pathways discovered in melanoma will be discussed in relationship to a more efficient anticancer strategy. In summary, this review tries to identify the most logical targets and the most useful mechanisms of tumor inhibition in light of new knowledge from the basic research including human genome project.
Keywords: apoptosis, angiogenesis, vasculogenic mimicry
Current Drug Targets
Title: Cellular Targets for Anticancer Strategies
Volume: 5 Issue: 4
Author(s): Caterina A.M. La Porta
Affiliation:
Keywords: apoptosis, angiogenesis, vasculogenic mimicry
Abstract: Since late 1950s the main strategies to treat cancer, besides surgery, have been radiotherapy or chemotherapy. These approaches work primarily by damaging proliferating cells at the level of DNA replication or cell division, and inducing apoptotic cell suicide as a secondary response to the damage. In recent years, efforts to improve cancer therapy have focused on the development of more selective, biological mechanism based approaches that can help to overcome tumor resistance as well as minimize toxic side effects. In the present review new strategies and new targets for biological cancer therapy will be discussed. In particular, new angiogenic pathways discovered in melanoma will be discussed in relationship to a more efficient anticancer strategy. In summary, this review tries to identify the most logical targets and the most useful mechanisms of tumor inhibition in light of new knowledge from the basic research including human genome project.
Export Options
About this article
Cite this article as:
La Porta A.M. Caterina, Cellular Targets for Anticancer Strategies, Current Drug Targets 2004; 5 (4) . https://dx.doi.org/10.2174/1389450043345434
DOI https://dx.doi.org/10.2174/1389450043345434 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Tumour Metastasis: The Emerging Role of Nanotechnology
Current Medicinal Chemistry Poly(lactic acid)-poly(ethylene oxide) Block Copolymers: New Directions in Self-Assembly and Biomedical Applications
Current Medicinal Chemistry Monoclonal Antibodies in Clinical Oncology
Anti-Cancer Agents in Medicinal Chemistry Estrogen Receptors: Molecular Interactions, Virtual Screening and Future Prospects
Current Topics in Medicinal Chemistry Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling
Current Genomics Non Polymeric Nanoparticles for Photodynamic Therapy Applications: Recent Developments
Current Medicinal Chemistry Application of Microbial Biotransformation for the New Drug Discovery Using Natural Drugs as Substrates
Current Pharmaceutical Biotechnology Cellular Senescence-Inducing Small Molecules for Cancer Treatment
Current Cancer Drug Targets Kisspeptin Mediated Signaling in Cancer
Current Topics in Medicinal Chemistry Lipids at the Cross-road of Autoimmunity in Multiple Sclerosis
Current Medicinal Chemistry Anti-Invasive and Anti-Metastasis Strategies: New Roads, New Tools and New Hopes
Current Cancer Drug Targets Biodistribution and Pharmacokinetics of I-131 Labelled 4- Iodophenylacetic Acid
Current Radiopharmaceuticals Protein Kinase B/AKT and Focal Adhesion Kinase: Two Close Signaling Partners in Cancer
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Cancer Biomarkers from Bench to Bedside)
Current Cancer Drug Targets Genetic Engineering of AAV Capsid Gene for Gene Therapy Application
Current Gene Therapy Deciphering the Role of Forkhead Transcription Factors in Cancer Therapy
Current Drug Targets MicroRNA Therapeutics: the Next Magic Bullet?
Mini-Reviews in Medicinal Chemistry Trends in Medical Image Compression
Current Medical Imaging Synthesis, Biological Activity of Thiazolidinones Bearing Indoline Moiety and Isatin Based Hybrids
Mini-Reviews in Organic Chemistry Bringing Light into the Diagnosis of Skin Disorders - Short Review on Laser Induced Fluorescence Spectroscopy and Optical Coherence Tomography in Dermatology
Current Medical Imaging